Dentsply Sirona appoints new CEO, prelim Q2 revenue beats estimates

Reuters
2025/07/21
Dentsply Sirona appoints new CEO, prelim <a href="https://laohu8.com/S/QTWO">Q2</a> revenue beats estimates

Overview

  • Dentsply Sirona appoints Daniel Scavilla as CEO, effective August 1, 2025

  • Company reports preliminary Q2 2025 revenue of $935 mln, beating expectations

  • Adjusted EPS for Q2 2025 expected between $0.50 and $0.52

Outlook

  • Company reaffirms 2025 outlook from May 8 earnings release

  • Dentsply Sirona expects Q2 2025 net sales of $935 mln

  • Company anticipates Q2 2025 adjusted EPS between $0.50 and $0.52

Key Details

Metric

Beat/Miss

Actual

Consensus Estimate

Q2 Preliminary revenue

Beat

$935 mln

$933.10 mln (13 Analysts)

Analyst Coverage

  • The current average analyst rating on the shares is "hold" and the breakdown of recommendations is 3 "strong buy" or "buy", 14 "hold" and no "sell" or "strong sell"

  • The average consensus recommendation for the medical equipment, supplies & distribution peer group is "buy."

  • Wall Street's median 12-month price target for DENTSPLY SIRONA Inc is $17.00, about 7.8% above its July 18 closing price of $15.68

  • The stock recently traded at 8 times the next 12-month earnings vs. a P/E of 8 three months ago

Press Release: ID:nGNX8BX9zy

(This story was created using Reuters automation and AI based on LSEG and company data. It was checked and edited by a Reuters journalist prior to publication.)

免責聲明:投資有風險,本文並非投資建議,以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請,作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考,不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證,投資者應自行研究並在投資前尋求專業建議。

熱議股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10